Novel gene disruptions, compositions and methods relating thereto

The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO286, PRO706, PRO1800, PRO4354, PRO6029, PRO9739, PRO20044, PRO28631 or...

Full description

Saved in:
Bibliographic Details
Main Authors SPARKS, MARY JEAN, PAYNE, BOBBY JOE, RANGEL, CAROLINA, BOLLINGER, KRISTI RAE, MINZE, LAURIE JEANETTE, DESAUVAGE, FREDERIC, GIRGIS, ROSEMARY, GREEN, LESLIE, SHI, ZHENG-SHENG, EDWARDS, JOEL A, VOGEL, PETER, TANG, TRACY TZU-LING
Format Patent
LanguageEnglish
French
German
Published 29.07.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO286, PRO706, PRO1800, PRO4354, PRO6029, PRO9739, PRO20044, PRO28631 or PRO34128 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular; endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.
Bibliography:Application Number: EP20090004542